The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
mRNA expression profiles in circulating tumor cells (CTCs) of patients with metastatic breast cancer (MBC) treated with aromatase inhibitors (AI).
Esther Anneke Reijm
No relevant relationships to disclose
Anieta M. Sieuwerts
No relevant relationships to disclose
Joan Bolt-de Vries
No relevant relationships to disclose
Bianca Mostert
No relevant relationships to disclose
Wendy Onstenk
No relevant relationships to disclose
Dieter Peeters
No relevant relationships to disclose
Luc Yves Dirix
No relevant relationships to disclose
Caroline Seynaeve
No relevant relationships to disclose
A. Jager
No relevant relationships to disclose
Felix E. de Jongh
No relevant relationships to disclose
Paul Hamberg
No relevant relationships to disclose
Anne M. van Galen
No relevant relationships to disclose
Jaco Kraan
No relevant relationships to disclose
Maurice P. H. M. Jansen
No relevant relationships to disclose
Jan-Willem Gratama
No relevant relationships to disclose
John A. Foekens
Research Funding - Veridex
John W. M. Martens
No relevant relationships to disclose
Els M. J. J. Berns
No relevant relationships to disclose
Stefan Sleijfer
Research Funding - Veridex